JP2018515089A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515089A5
JP2018515089A5 JP2017557457A JP2017557457A JP2018515089A5 JP 2018515089 A5 JP2018515089 A5 JP 2018515089A5 JP 2017557457 A JP2017557457 A JP 2017557457A JP 2017557457 A JP2017557457 A JP 2017557457A JP 2018515089 A5 JP2018515089 A5 JP 2018515089A5
Authority
JP
Japan
Prior art keywords
acylase
penicillin
engineered
insulin
engineered penicillin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017557457A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515089A (ja
JP6755886B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/031132 external-priority patent/WO2016179464A1/en
Publication of JP2018515089A publication Critical patent/JP2018515089A/ja
Publication of JP2018515089A5 publication Critical patent/JP2018515089A5/ja
Application granted granted Critical
Publication of JP6755886B2 publication Critical patent/JP6755886B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017557457A 2015-05-07 2016-05-06 ペニシリンｇアシラーゼ Active JP6755886B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562158118P 2015-05-07 2015-05-07
US62/158,118 2015-05-07
PCT/US2016/031132 WO2016179464A1 (en) 2015-05-07 2016-05-06 Penicillin-g acylases

Publications (3)

Publication Number Publication Date
JP2018515089A JP2018515089A (ja) 2018-06-14
JP2018515089A5 true JP2018515089A5 (enExample) 2019-04-11
JP6755886B2 JP6755886B2 (ja) 2020-09-16

Family

ID=57218075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017557457A Active JP6755886B2 (ja) 2015-05-07 2016-05-06 ペニシリンｇアシラーゼ

Country Status (13)

Country Link
US (6) US9944916B2 (enExample)
EP (1) EP3292136B1 (enExample)
JP (1) JP6755886B2 (enExample)
KR (1) KR102604503B1 (enExample)
CN (1) CN107531762A (enExample)
AU (1) AU2016258091B2 (enExample)
CA (1) CA2983620A1 (enExample)
DK (1) DK3292136T3 (enExample)
HU (1) HUE053863T2 (enExample)
IL (1) IL255245B (enExample)
MX (1) MX381306B (enExample)
SG (1) SG11201708356PA (enExample)
WO (1) WO2016179464A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107531762A (zh) 2015-05-07 2018-01-02 科德克希思公司 青霉素g酰化酶
KR102382489B1 (ko) 2016-05-05 2022-04-01 코덱시스, 인코포레이티드 페니실린 ｇ 아실라제
KR102696584B1 (ko) 2017-01-05 2024-08-19 코덱시스, 인코포레이티드 페니실린 ｇ 아실라아제
EP3645713A4 (en) * 2017-06-27 2021-06-30 Codexis, Inc. PENICILLIN-G ACYLASES
KR101985911B1 (ko) * 2017-12-28 2019-06-04 아미코젠주식회사 Achromobacter sp. CCM 4824 유래 페니실린 G 아실라제 변이체 및 이의 이용
CN109207466B (zh) * 2018-11-08 2021-01-08 山东鲁抗医药股份有限公司 一种青霉素酰化酶的固定化方法及固定化酶
KR102363768B1 (ko) * 2019-11-15 2022-02-16 아미코젠주식회사 세파졸린 생산성이 증가된 페니실린 g 아실라제 변이체 및 이의 이용
CN120699945A (zh) * 2024-10-08 2025-09-26 浙江师范大学行知学院 一种高活性青霉素g酰化酶突变体、编码核苷酸及其应用

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603344A (en) 1898-05-03 Trough for well-curbs
CA1338400C (en) 1983-08-31 1996-06-18 David H. Gelfand Recombinant fungal cellulases
US6869930B1 (en) * 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
CA2191718A1 (en) 1994-06-03 1995-12-14 Randy M. Berka Phosphonyldipeptides useful in the treatment of cardiovascular diseases
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
AU3346295A (en) * 1994-08-12 1996-03-07 Gist-Brocades B.V. Mutated penicillin g acylase genes
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
EP1717322B1 (en) 1997-01-17 2012-07-18 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
ATE286136T1 (de) 1998-10-06 2005-01-15 Mark Aaron Emalfarb Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
JP2002534965A (ja) 1999-01-19 2002-10-22 マキシジェン， インコーポレイテッド 所望の特徴を有する文字ストリング、ポリヌクレオチドおよびポリペプチドを作製するための方法
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
AU3391900A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Encryption of traits using split gene sequences
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
AU4964101A (en) 2000-03-30 2001-10-15 Maxygen Inc In silico cross-over site selection
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
EP2315145B1 (en) 2002-03-01 2015-11-25 Codexis Mayflower Holdings, LLC Methods, systems, and software for identifying functional biomolecules
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
SI1648933T1 (sl) * 2003-07-25 2010-01-29 Conjuchem Biotechnologies Inc Dolgo delujoäś inzulinski derivat in metoda zanj
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
ES2705694T3 (es) 2008-06-13 2019-03-26 Codexis Inc Método de síntesis de variantes de polinucleótidos
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
US8247192B2 (en) 2008-11-10 2012-08-21 Codexis, Inc. Penicillin-G acylases
MX2011006802A (es) * 2008-12-23 2011-07-20 Dsm Ip Assets Bv Acilasas de penicilina g mutante.
CN103074320B (zh) * 2012-05-25 2018-06-08 石药集团中奇制药技术（石家庄）有限公司 含有一个或几个点突变的青霉素g酰化酶
CN107531762A (zh) 2015-05-07 2018-01-02 科德克希思公司 青霉素g酰化酶

Similar Documents

Publication Publication Date Title
WO2016183438A8 (en) Self-targeting genome editing system
WO2013169806A3 (en) Biogenic activated carbon and methods of making and using same
WO2017181107A3 (en) Modified cpf1 mrna, modified guide rna, and uses thereof
JP2011516067A5 (enExample)
JP2013511481A5 (enExample)
MY189819A (en) Genetically modified cells and uses thereof
JP2016540516A5 (enExample)
NZ600546A (en) Excision of transgenes in genetically modified organisms
JP2016034965A5 (enExample)
JP2016525888A5 (enExample)
WO2014202616A3 (en) Rasamsonia gene and use thereof
JP2012065652A5 (enExample)
JP2014520527A5 (enExample)
PH12012501831B1 (en) Protein ipa1 related to plant architecture, its coding genes and uses
JP2013034479A5 (enExample)
RU2014147744A (ru) Способ обработки биомассы
JP2011174091A5 (enExample)
JP2010077130A5 (enExample)
JP2017513697A5 (enExample)
JP2023521772A5 (enExample)
MX2017006078A (es) Procedimiento para purificar una composicion cruda de dialquil ester de acido 2,5-furandicarboxilico.
PH12020551653A1 (en) Packaging oligonucleotides into virus-like particles
JP2013254783A5 (enExample)
CN104498971A (zh) 一种快速去除金属工件表面油灰的常温无磷脱脂剂
BR112012012915A2 (pt) bactéria pertencente à família enterobacteriaceae, e, método para produção de l-cisteína, l-cistina, um derivado das mesmas, ou uma mistura das mesmas